Skip to main content
. 2018 Jun 27;315(3):H563–H570. doi: 10.1152/ajpheart.00603.2017

Fig. 2.

Fig. 2.

Pressure-overload heart failure experimental protocol and survival rate. A: mice were subjected to transverse aortic constriction (TAC) surgery. NM922 or vehicle treatment was administered daily via intraperitoneal injection starting 6 wk after TAC and continued for 10 wk until the 16-wk end point. B: percent survival over the course of the study revealed that administration of NM922 resulted in 87% survival compared with 64% survival in vehicle-treated mice. LV, left ventricular.